Ireland’s Supply Chain Suffers Due To Brexit And Covid
As Majority Of Companies Report Delays On Imports And Exports
Medicines for Ireland has released a report focusing on the direct impact of Brexit and COVID-19 on the medicines supply chain. The association has called for long-term plans and solutions instead of temporary fixes for issues related to delays in the import and export of medicines.
You may also be interested in...
Medicines for Ireland has welcomed the inclusion of the off-patent industry association in negotiations with government and other industry stakeholders for a new Irish framework agreement on the supply of medicines.
Action is needed from both the UK government and the European Commission to prevent a collapse of Northern Ireland’s generics market, according to the BGMA.
Kelix bio has announced two deals to expand its presence in Africa. The company is set to acquire 14 oncology injectable products from Germany-based Vitane. Furthermore, Kelix has acquired Pharmaceutical Institute, a pharmaceutical company established in Rabat, to enter Morocco. The pan-African company has also invested in Malta.